What Should You Know About RE/MAX Before Investing?

Shares of Finance sector company RE/MAX moved 0.5% today, and are now trading at a price of $19.28. The small-cap stock's daily volume was 29,862 compared to its average volume of 136,496. The S&P 500 index returned a 0.0% performance.

RE/MAX Holdings, Inc. operates as a franchisor of real estate and mortgage brokerage services in the United States, Canada, and internationally. The company is based in Denver and has 594 full time employees. Its market capitalization is $600,616,384. RE/MAX currently offers its equity investors a dividend that yields 4.8% per year.

4 analysts are following RE/MAX and have set target prices ranging from $20.0 to $24.0 per share. On average, they have given the company a rating of hold. At today's prices, RMAX is trading -11.36% away from its average analyst target price of $21.75 per share.

Over the last year, RMAX shares have gone down by -23.6%, which represents a difference of -20.0% when compared to the S&P 500. The stock's 52 week high is $28.25 per share and its 52 week low is $16.78. Although RE/MAX's average free cash flow over the last four years has been $54,526,500.0, they have been decreasing at an average rate of -1.8%. For this reason, investors may continue to shun the stock.

Date Reported Cash Flow from Operations ($ k) Capital expenditures ($ k) Free Cash Flow ($ k) YoY Growth (%)
2022-12-31 71,142 -9,932 61,210 125.01
2021-12-31 42,442 -15,239 27,203 -57.46
2020-12-31 70,847 -6,903 63,944 -2.75
2019-12-31 78,975 -13,226 65,749 n/a
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS